Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
AMGN
AMGEN INC
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$414.87
· 2026-10-09
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$227.88B
RECENT INSIDER TRADES
2026-08-13
· Khosla Rachna
(SVP, Business Development)
· OTHER
2026-08-13
· Khosla Rachna
(SVP, Business Development)
· SELL
2026-08-12
· Busch Matthew C.
(VP, Finance & CAO)
· OTHER
2026-08-10
· ISHRAK OMAR
(Director)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
3,446
Shares held
557,920,503
Value
$192.69B
Percent of shares outstanding
103.20%
As of quarter end
2026-09-30
RECENT CONGRESSIONAL TRADES
2026-09-22
· Hon. David J. Taylor · BUY
· $1,001 - $15,000
2026-08-26
· David Taylor · SELL
· $1,001 - $15,000
2026-08-25
· David Taylor · SELL
· $1,001 - $15,000
2026-08-12
· Sheldon Whitehouse · SELL
· $1,001 - $15,000
2026-06-05
· David Taylor · BUY
· $1,001 - $15,000
RECENT NEWS
Cantor Fitzgerald raises Amgen price target on portfolio strength
AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot
David J. Taylor Purchases Amgen and Home Depot Stocks, Sells Marathon Petroleum
Amgen Research Offers Clue to Weight-Loss Drug Paradox
Teva wins biosimilar approval of Amgen's Xgeva
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS